XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

AIDS Channel
subscribe to AIDS newsletter

Latest Research : Infectious Diseases : AIDS

   DISCUSS   |   EMAIL   |   PRINT
Contaminated needles not contributing to spread of HIV in sub-Saharan Africa
Feb 23, 2005, 20:30, Reviewed by: Dr.

"Some have speculated that unsafe medical injections are driving the continuing spread of HIV in many sub-Saharan African countries, but with this research we are now able to confidently exclude injections as a major transmission route"

 
Injections with dirty or contaminated needles are not contributing to the spread of HIV in sub-Saharan Africa say researchers from Imperial College London and the Biomedical Research and Training Institute, Zimbabwe.

Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.

Dr Ben Lopman from Imperial College London, based at St Mary's Hospital, and one of the researchers, says: "Some have speculated that unsafe medical injections are driving the continuing spread of HIV in many sub-Saharan African countries, but with this research we are now able to confidently exclude injections as a major transmission route."

The researchers analysed data from the Manicaland HIV/STD Prevention Study, which had recruited 1847 men and women aged between 15 and 54 to the three year study. The study collected a range of health and socio-demographic data including self-reported history of STD symptoms and whether the participants had received any medical injections or needle pricks.

40.3 percent received an injection or needle prick during the three year study period, but these individuals were no more likely to acquire HIV than individuals who did not receive injections.

Despite the increased number of injections involved with childbearing and pregnancy there was no link to increased risk of HIV infection.

Dr Simon Gregson, from the Biomedical Research and Training Institute in Harare, Zimbabwe, and one of the researchers, says: "Clearly, it is still possible for an individual to get HIV through unsafe medical injections, but, overall in this population in Zimbabwe, unsafe injections are not an important cause of HIV infection.
 

- Public Library of Science Medicine
 

PLOS Medicine

 
Subscribe to AIDS Newsletter
E-mail Address:

 

The Manicaland HIV/STD Prevention Study was supported by the Wellcome Trust, UNAIDS and CDC Zimbabwe.

Related AIDS News

Keeping A3G in action represents a new way to attack HIV
Fighting HIV With HIV Virus Itself
HIV exploits competition among T-cells
Harmless GB Virus type C (GBV-C) protects against HIV infection
Study defines effective microbicide design for HIV/AIDS prevention
HIV depends on human p75, study shows
Simplified treatment of HIV infection shows promise
Clinical trial evaluates first-line approaches for treating HIV
T cells activated to fight HIV basis for dendritic cell therapeutic vaccine
B cells with special protein direct HIV to T cells


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us